Oxford Biomedica (OXB) RNS Announcements

Add to Alert list
Date Time Source Announcement
24 Oct 2008 04:36 PM
RNS
Price Monitoring Extension
24 Oct 2008 07:00 AM
RNS
TroVax Phase I and II data
23 Oct 2008 04:43 PM
RNS
Second Price Monitoring Extn
23 Oct 2008 04:37 PM
RNS
Price Monitoring Extension
22 Oct 2008 04:45 PM
RNS
Second Price Monitoring Extn
22 Oct 2008 04:36 PM
RNS
Price Monitoring Extension
14 Oct 2008 04:44 PM
RNS
Second Price Monitoring Extn
14 Oct 2008 04:38 PM
RNS
Price Monitoring Extension
14 Oct 2008 07:00 AM
RNS
Major Interest in Shares
13 Oct 2008 04:42 PM
RNS
Second Price Monitoring Extn
13 Oct 2008 04:37 PM
RNS
Price Monitoring Extension
13 Oct 2008 07:00 AM
RNS
Board Appointment
08 Oct 2008 04:45 PM
RNS
Second Price Monitoring Extn
08 Oct 2008 04:39 PM
RNS
Price Monitoring Extension
07 Oct 2008 07:00 AM
RNS
FDA AGREEMENT ON TROVAX® PHAS
29 Sep 2008 04:43 PM
RNS
Second Price Monitoring Extn
29 Sep 2008 04:37 PM
RNS
Price Monitoring Extension
26 Sep 2008 04:35 PM
RNS
Price Monitoring Extension
18 Sep 2008 07:00 AM
RNS
UBS Global Life Sciences Conf
10 Sep 2008 03:10 PM
RNS
Director Shareholding
09 Sep 2008 07:00 AM
RNS
Interim data for ProSavin
08 Sep 2008 04:42 PM
RNS
Second Price Monitoring Extn
08 Sep 2008 04:36 PM
RNS
Price Monitoring Extension
02 Sep 2008 04:41 PM
RNS
Second Price Monitoring Extn
02 Sep 2008 04:35 PM
RNS
Price Monitoring Extension
29 Aug 2008 07:00 AM
RNS
Board Change
29 Aug 2008 07:00 AM
RNS
Interim Results
27 Aug 2008 04:33 PM
RNS
Notice of Interim Results
18 Aug 2008 10:21 AM
RNS
Notification of Major Interes
15 Aug 2008 01:19 PM
RNS
Rule 2.10 Announcement
15 Aug 2008 11:38 AM
RNS
Rejection of GeneThera's indi
28 Jul 2008 07:00 AM
RNS
Board Appointment
15 Jul 2008 04:13 PM
RNS
TROVAX Phase III TRIST Study
14 Jul 2008 08:48 AM
RNS
TroVax QUASAR Trial
11 Jul 2008 07:00 AM
RNS
RECOMMENDATION FOR TROVAX® PH
01 Jul 2008 09:10 AM
RNS
RESPONSE TO BAVARIAN NORDIC'S
01 Jul 2008 07:00 AM
RNS
Board Changes
24 Jun 2008 07:00 AM
RNS
JEFFERIES HEALTHCARE CONFEREN
02 Jun 2008 07:00 AM
RNS
Trovax Phase II Trial Results
30 May 2008 03:28 PM
RNS
Blocklisting Return
30 May 2008 03:25 PM
RNS
Total Voting Rights Update
27 May 2008 10:25 AM
RNS
FBR Capital Markets Spring In
19 May 2008 07:00 AM
RNS
Rodman & Renshaw Healthcare C
16 May 2008 07:00 AM
RNS
Phase II Trial Results
09 May 2008 01:48 PM
RNS
Annual General Meeting
09 May 2008 07:00 AM
RNS
Interim Management Statement
30 Apr 2008 11:42 AM
RNS
Total Voting Rights
15 Apr 2008 07:00 AM
RNS
Board changes
03 Apr 2008 08:35 AM
RNS
Annual Information Update
01 Apr 2008 04:18 PM
RNS
Major Interest in Shares

Oxford Biomedica is a company that specialises in cell and gene therapy, and is a leader in the development of gene-based medicines. They work with pharmaceutical and biotechnology companies to develop and manufacture viral vectors, including lentivirus, adeno-associated virus, and adenoviral vectors.

Headquartered in Oxford, Oxford Biomedica has manufacturing facilities in Oxfordshire, UK, Lyon and Strasbourg, France, and near Boston, MA, US.

Oxford Biomedica share price listed in London under the ticker OXB at 2,570p.

UK 100

Latest directors dealings